Form 8-K DEXCOM INC For: Jul 26

Go back to Form 8-K DEXCOM INC For: Jul 26

DexCom (DXCM) PT Lowered to $105 at Oppenheimer; 'Buying on Weakness'

July 29, 2022 7:25 AM EDT

Oppenheimer analyst Steven Lichtman lowered the price target on DexCom (NASDAQ: DXCM) to $105.00 (from $525.00) while maintaining an Outperform rating following weak results. The analyst is buying on weakness.

The analyst commented, "DexCom's 2Q22 sales of $696.2M (+17% y/y) slightly lagged our/Street's... More